RGNX
Biotechnology · Healthcare
CFO
Equibles does not estimate personal net worth.
Get an email with a short summary when REGENXBIO Inc. publishes a filing, an earnings call transcript or a press release.
Get RGNX alertsMitch Chan is recorded as CFO at REGENXBIO Inc. (RGNX). Mitch Chan has spoken on 2 earnings calls and 1 other investor event across 1 company, most recently for REGENXBIO Inc. on September 16, 2026. REGENXBIO Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at REGENXBIO Inc. includes Curran M. Simpson (CEO, COO and Board Member), Allan M. Fox (Chairman and Board Member), George Migausky (Chairman and Board Member) and 7 others.
“So our Cash Runway right now will get us to Q4 of 2027, which is very important. is well past the key catalyst for both 314 as well as 202 and well past the regulatory fronts.”
“Regenix Bell ended the second quarter of 2026 with cash, cash equivalent, and marketable securities of $106 million.”
“REGENXBIO ended the quarter on September 30, 2025, with cash, cash equivalents, and marketable securities of $302 million compared to $245 million as of December 31, 2024.”
RGNX
Biotechnology · Healthcare
CFO